As of Friday, December 12, Anixa Biosciences, Inc.’s ANIX share price has dipped by 18.33%, which has investors questioning if this is right time to buy.

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

ANIXA BIOSCIENCES INC (ANIX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

) has been revised to $10.20 / share. This is an increase of 11.11% from the prior estimate of $9.18 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...

The healthcare company presented final data Thursday at the 2025 San Antonio Breast Cancer Symposium. The trial, conducted with the Cleveland Clinic and funded by a U.S. Department of Defense grant, ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

ANIX has a dual-platform approach. It has an FSHR‑targeted CAR‑T program for ovarian cancer and an α‑lactalbumin breast cancer vaccine. Their Phase 1 CAR‑T showed reasonable safety, as one patient ...

As of 9:55:43 a.m. EST. Market Open.

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...